BD plans $3 billion US manufacturing expansion

BD plans $3 billion in US medical-product manufacturing within a broader $19 billion multiyear investment commitment, OAN and Reuters report. The agreement ties future tariff relief on covered products and inputs to agreed milestones and the final scope of tariff measures. The spending and expanded domestic supply are plans, rather than completed production.